ÍøºìºÚÁÏ

Skip to main content

Mohammed Ruzieh, MD

Cardiologist (Heart Specialist)

Photo of Mohammed Ruzieh

Research at a glance

Top areas of exploration

  • Postural Orthostatic Tachycardia Syndrome , 7 publications
  • Pulmonary Embolism , 6 publications
  • Cardiovascular Diseases , 5 publications
  • Biomarkers , 4 publications

Research activity

71 publications

379 citations

Why is this important?

Active clinical trials

Librexia AF

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.

Investigator
Mohammed Ruzieh
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

71 publications

2023

Letter by Jiao and Ruzieh Regarding Article, “Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sexâ€

Circulation

2023

Longitudinal cardiac remodeling in collegiate American football players as assessed by echocardiography during their collegiate career.

Clinical cardiology

•

2022

Resource Utilization Following Coronary Computed Tomographic Angiography and Stress Echocardiography in Patients Presenting to the Emergency Department With Chest Pain.

The American journal of cardiology

•

2022

The Slower, the Better: Wide Complex Tachycardia Triggered by Flecainide in an Elderly Female

Case Reports in Cardiology

•

2021

Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.

JAMA network open

•